ISSN 2500-2236
DOI-prefix: 10.18527/2500-2236

Current Issue

Volume 4, Number 1, 2017

About the Journal


The Microbiology Independent Research (MIR) journal is a new, international resource for academic researchers and professionals in the pharmaceutical and biopharmaceutical industry. The journal publishes strictly peer-reviewed papers that cover novel aspects in virology, bacteriology, and mycology.

One of the main goals of the MIR Journal is to increase the number of publications from Russian scientists in English in order to introduce them to the context of world science.

All submitted articles are peer-reviewed and upon acceptance are published in English on the MIR journal website in open access format – free of charge for the readers. Quick, easy, and convenient access to the full text of articles allows for bringing the information about the occurrence, properties, and distribution of the known and newly emerging infectious agents immediately to the scientific community and practicing medical personnel. This is absolutely necessary for timely measures to be implemented in order to combat disease. 

Why do we need a new open access journal devoted to microbiology?


MIR features:

  • Editorials
  • Research Articles
  • Short communications
  • Reviews
  • Commentaries

This journal is published online only.


Scope

Fully comprehensive in its scope, MIR journal highlights important discoveries in all aspects of microbiology, including

  • (i) virology,
  • (ii) bacteriology, and
  • (iii) mycology.

In particular, the journal publishes articles devoted to the

  • (i) nature of microorganisms,
  • (ii) pathogenesis,
  • (iii) genetic diversity and evolution,
  • (iv) immunity,
  • (v) development and evaluation of vaccines,
  • (vi) antimicrobial agents,
  • (vii) adjuvants and immunomodulators, 
  • (viii) epidemiology,
  • (ix) assay development, and
  • (x) new animal models.

Special attention is also paid to new antiviral or antimicrobial drugs, development and evaluation of vaccines, the immune response to vaccines in humans and animals, new vaccine approaches, vaccine vectors, and clinical trial results, including phases 1 through 3.

Alongside each highlighted topic, the journal publishes original papers in the form of Research Articles or Rapid Communications and Reviews illustrating or related to the latest research results.


Publication charges

MIR journal provides an open access to all published papers from the first day of publishing. Therefore, all journal expenses are recovered by charging a publication fee to all authors or their sponsors. However, the fee varies according to the country-based pricing model. The authors submitting the publication from the High Income Countries are required to pay complete fee 500 Euro.

The price for the authors from the Low Income Countries is 300 Euro. However, if the research was not financially supported, the MIR Financial department can consider the request to reduce the price (finance@mir-journal.org). The decision will be based on the scientific significance of the submitted paper.


Language Policy

MIR accepts manuscripts in the English and Russian languages. For articles written in English, only a US English version will be published. The Abstract will be translated into Russian and published on the Russian site of the Journal. Articles written in Russian will be reviewed and, upon acceptance, translated into English. Both versions (Russian and English) will be available online with separate DOI numbers. The expenses for the translation of Russian articles into English are covered by the publication fee. In addition, the authors are offered a proofreading service by English native speakers. To order proofreading, please contact us at editor@mir-journal.org


Peer-review policy

External reviewers review all of the articles submitted to the editorial board. An article is considered accepted for publication if it has received at least two positive reviews. The names of the reviewers are not disclosed to authors.


Privacy policy

MIR journal is committed to ensuring that the author privacy is protected. The authors can be assured that all of the private information that is provided to the editorial board will be used strictly in accordance with this privacy statement.


Copyright Declaration

MIR journal operates according to the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License (CC-BY-NC-SA license). According to this license, the authors keep the copyright for the contents of the Article, but anyone, hereinafter referred as “Licensee”, has the right to download, reuse, reprint, translate to a different language, copy, and/or distribute the contents of the Article as long as the material is not used for commercial purposes provided that a new publication will have a reference to the authors of the original Article and the journal that the original Article was first published in, and that this publication will have the corresponding licensing. This license also gives the right for Licensee to edit, change, or build on the text of the original Article and publish this material provided that a new publication will have a reference on the authors of the original Article and the journal that the original Article was first published in, and that this publication will have the corresponding licensing. If the Publisher does not like how the material has been modified or used, CC-BY-NC-SA license requires that the Licensee removes the attribution information upon the Publisher’s request.

The appropriate attribution can be provided by presenting the reference to the original paper. E. g., Egorov AY. The challenges of creating a universal influenza vaccine. MIR J 2016, 3 (1), 31-41 DOI: 10.18527 / 2500-2236-2016-3-1 -31-41)

Reference for the License:

http://creativecommons.org/licenses/by-nc-sa/3.0/deed.en


Conflict of interest

All of the authors of each publication must certify that they are not involved in any entity with any financial interest in the subject matter or materials discussed in the manuscript.


Publication Ethics

MIR Regulations on Publication Ethics were developed in accordance with the recommendations of COPE's (Committee on Publication Ethics) Best Practice Guidelines  

1. Duties of the Editor-in-chief and Editorial Board

1.1. Decision about the publication of manuscript
Editor-in-chief and Editorial Board of the MIR Journal make decisions to accept or reject the manuscripts for publication based solely on the content and scientific value of the submitted manuscript.

1.2. Confidentiality
Editor and all the members of Editorial Board should treat all the information related to the submitted manuscripts as strictly confidential.

1.3.  Conflicts of interests
Editor-in-chief and the members of Editorial Board should not use the information from the submitted manuscripts in their personal interests. The Editorial Board should reveal any possible conflicts of interests.

1.4. Complaints handling
The Editor-in-chief and members of Editorial Board should resolve all conflicts, complaints or claims arising in connection with the submitted manuscript.

2. The Duties of reviewers
According to the MIR rules every paper is reviewed minimum by two reviewers. If they have different recommendations on acceptance of the manuscript, the manuscript is send to a third reviewer. The names of reviewers are not communicated to the author.

2.1. Decision about publication
The reviewer should make an expert assessment of the manuscript solely on the basis of its content and should express his opinion on the acceptance of the manuscript for publication. The reviewer also can express his suggestions on improving the manuscript. Personal criticism of the author is not acceptable.

2.2. The terms of manuscript review
The reviewer, who agreed to review the manuscript, should comply within the time frame set by the editorial office for writing the review of the manuscript. In case the reviewer cannot meet the deadline for the reviewing of the manuscript, he/she should notify the editorial office.

2.3. Confidentiality

The reviewers should keep all the information concerning the manuscript in confidence. It is unacceptable to discuss the manuscript with the third parties without the consent of the editor.

2.4. Proof of novelty                 
The reviewer should verify the correctness of the given conclusions and adequacy (or accordance) of the references, identify similar publications.

2.5. Conflicting parties
All and any information that became available for the reviewer in the course of the manuscript reviewing should not be used for their self-profit. The reviewer should inform MIR editorial office about any conflict of interests. The reviewer should not consider for review the manuscripts of authors, if he/she has a competitive position on the subject of research, described in the manuscript.

3.  Author's duties

3.1 Standards
Authors should guarantee, that the submitted manuscripts describe results of their own original research. If the submitted manuscript describes the continuation of the research project, the references to the previous studies on this topic should be presented.

3.2 Access to the data
The authors of the manuscript should cite all the data sources, which they used while they were writing the manuscript. The authors should be ready to present the original data supporting the results published in their manuscript to editorial office for review.

3.3. Originality and plagiarism
The authors should guarantee, that the research, described in the manuscript, is original and the manuscript was not published earlier in a different journal (elsewhere). Plagiarism in any form is not acceptable.

is published online only